High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 129-134

  Miida, Takashi ^a   Yamaguchi, Toshio ^b   Tsuda, Takashi ^b   Okada, Masahiko ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Kido Hospital   (Japan)

Author keywords

Apolipoprotein A I; Cholesteryl ester transfer protein (CETP); Diet therapy; Prep HDL; Probucol; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; PROBUCOL; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LIPID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRE BETA HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CHOLESTEROL INTAKE; DIET THERAPY; MIDDLE AGED;

AGED; ANTICHOLESTEREMIC AGENTS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, DIETARY; FEMALE; GLYCOPROTEINS; HIGH-DENSITY LIPOPROTEINS, PRE-BETA; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROBUCOL;

EID: 0032059165     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00011-2     Document Type: Article

References (30)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR High density lipoprotein as a protective factor against coronary heart disease: Framingham study. Am J Med. 62:1977;707-714.
2. Watkins LO, Neaton JD, Kuller LH High-density lipoprotein cholesterol and coronary heart disease racial differences in incidence in the usual care group of the multiple riskk factor intervention trial. Am J Cardiol. 57:1986;538-545.
3. Miller NE, Førde OH, Thelle DS, Mjøs OD The Tromsø-heart study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet. i:1977;965-968.
4. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr., Bangdiwala S, Tyroler HA High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:1989;8-15.
5. Fielding CJ, Fielding PE Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
6. Castro GR, Fielding CJ Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27:1988;25-29.
7. Francone OL, Gurakar A, Fielding C Distribution and function of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem. 264:1989;7066-7072.
8. Miida T, Fielding CJ, Fielding PE Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasma. Biochemistry. 29:1990;10469-10474.
9. Fielding PE, Miida T, Fielding CJ Metabolism of low-density lipoprotein free cholesterol by human plasma lecithin-cholesterol acyltransferase. Biochemistry. 30:1991;8551-8557.
10. Huang Y, von Eckardstein A, Assmann G Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb. 13:1993;445-458.
11. II particles. Biochem Biophys Res Commun. 142:1987;63-69.
12. Ohta T, Saku K, Takata K, Nakamura R, Ikeda Y, Matsuda I Different effects of subclasses of HDL containing apo A-I but not apo A-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb. 15:1995;956-962.
13. Kawano M, Miida T, Fielding CJ, Fielding PE Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry. 32:1993;5025-5028.
14. Miida T, Nakamura Y, Inano K, Matsuto T, Yamaguchi T, Tsuda T, Okada M Preβ1-HDL increases in coronary artery disease. Clin Chem. 42:1996;1992-1995.
15. Miida T, Inano K, Yamaguchi T, Tsuda T, Okada M LpA-I levels do not reflect preβ1-HDL levels. Atherosclerosis. 133:1997;221-226.
16. Francone OL, Royer L, Haghpassand M Increased preβ-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgenes. J Lipid Res. 37:1996;1268-1277.
17. Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Arteriosclerosis. 9:1989;462-469.
18. McPherson R, Hogue M, Milne RW, Tall AR, Mercel YL Increase in plasma cholesteryl ester transfer protein during probucol treatment: relation to changes in high density lipoprotein composition. Arterioscler Thromb. 11:1991;476-481.
19. Ishigami M, Yamashita S, Sakai N, Hirano K, Arai T, Maruyama T, Takami S, Koyoma M, Kameda-Takemura K, Matsuzawa Y High-density liproproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded acetylated low-density lipoproteins. Eur J Clin Invest. 27:1997;285-292.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment PanelII). J Am Med Assoc. 269:1993;3015-3023.
21. Kato H, Nakanishi T, Arai H, Nishida HI, Nishida T Purification, microheterogeneity, and stability of human lipid transfer protein. J Biol Chem. 264:1989;4082-4087.
22. Ishida BY, Frolich J, Fielding CJ Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res. 28:1987;778-786.
23. Ishida BY, Albee D, Paigen B Interconversion of prebeta-migrating lipoproteins containing apolipoprotein A-I and HDL. J Lipid Res. 31:1990;227-236.
24. Jiao J., Cole TG, Kitchens TT, Pfleger B, Schonfeld G Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography. Metabolism. 39:1990;155.
25. Kunitake ST, Mendel CM, Hennessy LK Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res. 33:1992;1807-1816.
26. Hennessy LK, Kunitake ST, Kane JP Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-β high- density lipoprotein particles. Biochemistry. 32:1993;5759-5765.
27. Melchior GW, Castle CK, Murray RW, Blake WL, Dinh DM, Marotti KR Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels. J Biol Chem. 269:1994;8044-8051.
28. Kouzuma R, Tasaki H, Komura T, Nakashima Y, Kuroiwa A, Tanimoto A, Koide O Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 1% choletsterol diet in rabbit aorta. Artery. 21:1995;337-351.
29. Tomochika Y, Okuda F, Tanaka N, Wasaki Y, Tokisawa I, Aoyagi S, Morikuni C, Ono S, Okada K, Matsuzaki M Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol-lowering therapies in familial hypercholesterolemia. Arterioscler Thromb. 16:1996;955-962.
30. Walldius G., Erikson U., Olsson A.G., Bergstrand L., Hådell K., Johansson J., Kaijser L., Lassvik C., Mölgaard J., Nilsson S., Schäfer-Elinder L., Stenport G., Holme I. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol. 74:1994;875-883.